Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Casein kinase I delta (CK1δ) is a serine/threonine-specific protein kinase involved in regulating diverse cellular processes, including circadian rhythm, microtubule dynamics, Wnt signaling, and DNA repair. It is considered a therapeutic target due to its involvement in cancer and neurodegenerative diseases. The activity of CK1δ is modulated through phosphorylation within its C-terminal domain. There is active research into developing selective inhibitors that account for regulatory modifications such as C-terminal phosphorylation states.
Kinase inhibitor
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Casein Kinase I Delta (CK1δ).